FIELD: medicine; pharmacology.
SUBSTANCE: invention concerns dispersed tablets, the formula including compounds of the formula (1) 
in amount of 5-40% wt. and, at least, one aerating agent in amount of 10-35% wt, and the method of its obtaining.
EFFECT: tablets possess an improved profile of dissolution.
14 cl, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CEFACLOR PHARMACEUTICAL PREPARATIVE FORM AND METHOD OF ITS PREPARING | 1995 |
|
RU2150276C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ALPELISIB | 2015 |
|
RU2690685C2 |
| TABLET WITH HIGH CONTENT OF MEDICATION | 2009 |
|
RU2405540C1 |
| TABLET WITH HIGH DRUG CONTENT | 2003 |
|
RU2363450C2 |
| HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
| NEW PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2779429C2 |
| GALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2009 |
|
RU2438661C2 |
| PHARMACEUTICAL COMPOSITION OF N-[5-[2-(3,5-DIMETHOXYPHENYL) ETHYL]-2H-PYRAZOL-3-YL]-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL] BENZAMIDE | 2013 |
|
RU2674978C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MYCOPHENOLIC ACID OR ITS SALT (MYCOPHENOLATE) | 2007 |
|
RU2381026C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
